Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cognitive Impairment
- Ovarian Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: Phase 1 will be a dose-escalating design. Phase 2 will be a randomized, double-blinded, placebo-controlled study designMasking: Double (Participant, Investigator)Masking Description: Phase 1 will be open label. Phase 2 will be be double-blinded.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04520139
- Collaborators
- Jarrow Formulas Inc
- Investigators
- Principal Investigator: Daniela Bota, MD, PhD Chao Family Comprehensive Cancer Center
Get Well Soon